Status:
UNKNOWN
Multiwave Locked System Laser for Patients With Bell's Palsy.
Lead Sponsor:
Umm Al-Qura University
Conditions:
Facial Paralyses, Idiopathic
Laser Therapy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: Idiopathic Bell's palsy (IBP) is a unilateral facial paralysis of sudden onset and unknown etiology. Patient with IBP has an impaired facial expressions and psychological affection, which ...
Detailed Description
Multi-wave locked system (MLS) laser therapy had been presented in the arena of rehabilitation and attained interests of numerous researchers due to its unique features. MLS laser is a Class IV, high-...
Eligibility Criteria
Inclusion
- Any patient who has unilateral IBP either on the right or left side.
- Treatment will begin in the sub-acute stage of illness 3-5 days after the acute onset subsided.
- patients will accept to attend to the physical therapy department to receive their corresponding treatment twice a week for successive six weeks.
Exclusion
- Patients who have central nervous system pathology
- sensory loss over the face, or recurrence of BP.
- Patients with upper motor facial nerve palsy will be also excluded.
- Any infant or child (≤18 years) with BP will be also excluded.
- Chronic facial palsy patients
- Patients BP having after a tumor, stroke, and Lyme disease will be excluded.
Key Trial Info
Start Date :
January 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05270187
Start Date
January 10 2022
End Date
April 1 2022
Last Update
March 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Umm Al-Qura University, Faculty of Applied Medical Science
Mecca, Saudi Arabia, 21955